E Goguet, CH Olsen, WA Meyer III, S Ansari… - Frontiers in …, 2024 - frontiersin.org
Introduction We sought to determine pre-infection correlates of protection against SARS- CoV-2 post-vaccine inzfections (PVI) acquired during the first Omicron wave in the United …
F Pieralli, F Pomero, F Dentali, C Norbiato… - BMC Infectious …, 2023 - Springer
Background Remdesivir is widely used for treatment of SARS-CoV-2 pneumonia. The aim of this study was to evaluate the characteristics of patients with moderate-to-severe COVID-19 …
TL Conner, E Goguet, H Haines-Hull, A Segard… - medRxiv, 2024 - medrxiv.org
This study characterized antibody responses induced by COVID-19 mRNA vaccination and SARS-CoV-2 infection in saliva. Utilizing multiplex microsphere-based immunoassays, we …
HM O'Grady, D Dixit, Z Khawaja… - Infection Control & …, 2023 - cambridge.org
Asymptomatic coronavirus disease 2019 (COVID-19) has been reported as a significant driver of COVID-19 outbreaks. Our hospital ward outbreak analysis suggests that …
ASARS Coronavirus, HM O'Grady, D Dixit, Z Khawaja… - scholar.archive.org
Asymptomatic COVID-19 has been reported as a significant driver of COVID-19 outbreaks. Our hospital ward outbreak analysis suggests that comprehensive symptoms and signs …